Financials
- Market Capitalization 22.99 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
13.29
市销率
3.54
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 519 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 56.31 USD | +1.15% | -3.45% | +3.87% | +51.13% | 25.04 B USD | ||
| 535 | INSM Insmed Incorporated - Common Stock | 109.81 USD | -0.27% | -5.69% | +15.47% | -32.24% | 23.80 B USD | ||
| 555 | UTHR United Therapeutics Corporation - Common Stock | 531.79 USD | +0.97% | -4.07% | -3.20% | +79.17% | 22.57 B USD | ||
| 567 | BNTX BioNTech SE - American Depositary Shares | 91.99 USD | +1.76% | -1.72% | +2.21% | -17.53% | 22.07 B USD |